🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/12/2010 | 5,58 | 5,64 | 5,55 | 5,60 | -0,11% | 1,56% | 116.378 |
| 23/12/2010 | 5,65 | 5,70 | 5,60 | 5,60 | -0,99% | 1,77% | 295.273 |
| 22/12/2010 | 5,70 | 5,72 | 5,61 | 5,66 | -0,87% | 1,97% | 321.081 |
| 21/12/2010 | 5,71 | 5,71 | 5,46 | 5,71 | +0,77% | 4,48% | 179.696 |
| 20/12/2010 | 5,59 | 5,75 | 5,55 | 5,66 | +2,14% | 3,68% | 253.114 |
| 17/12/2010 | 5,44 | 5,56 | 5,40 | 5,55 | +2,30% | 3,10% | 538.287 |
| 16/12/2010 | 5,35 | 5,45 | 5,35 | 5,42 | +1,28% | 1,98% | 139.942 |
| 15/12/2010 | 5,32 | 5,37 | 5,30 | 5,35 | +0,71% | 1,29% | 255.679 |
| 14/12/2010 | 5,32 | 5,36 | 5,32 | 5,32 | +0,00% | 0,94% | 105.798 |
| 13/12/2010 | 5,28 | 5,33 | 5,25 | 5,32 | +0,83% | 1,54% | 192.841 |
| 10/12/2010 | 5,27 | 5,30 | 5,20 | 5,27 | +0,48% | 1,90% | 190.597 |
| 09/12/2010 | 5,33 | 5,33 | 5,20 | 5,25 | -0,71% | 2,46% | 142.186 |
| 08/12/2010 | 5,36 | 5,37 | 5,27 | 5,28 | -1,51% | 1,86% | 171.681 |
| 07/12/2010 | 5,35 | 5,40 | 5,33 | 5,36 | +1,17% | 1,28% | 118.462 |
| 06/12/2010 | 5,28 | 5,31 | 5,28 | 5,30 | +0,00% | 0,59% | 93.936 |
| 03/12/2010 | 5,27 | 5,32 | 5,27 | 5,30 | +0,00% | 0,83% | 52.098 |
| 02/12/2010 | 5,25 | 5,36 | 5,25 | 5,30 | +0,95% | 2,02% | 128.400 |
| 01/12/2010 | 5,36 | 5,36 | 5,24 | 5,25 | -0,24% | 2,21% | 119.904 |
| 30/11/2010 | 5,18 | 5,27 | 5,18 | 5,27 | +0,84% | 1,81% | 207.589 |
| 29/11/2010 | 5,21 | 5,25 | 5,16 | 5,22 | -0,47% | 1,80% | 99.707 |
| 26/11/2010 | 5,27 | 5,30 | 5,25 | 5,25 | -1,29% | 1,07% | 19.717 |
| 24/11/2010 | 5,11 | 5,33 | 5,11 | 5,32 | +3,02% | 4,39% | 137.698 |
| 23/11/2010 | 5,11 | 5,29 | 5,08 | 5,16 | +0,00% | 4,15% | 111.248 |
| 22/11/2010 | 5,66 | 5,66 | 5,12 | 5,16 | -8,82% | 9,58% | 201.818 |
| 19/11/2010 | 8,47 | 9,23 | 5,63 | 5,66 | -0,55% | 42,52% | 319.638 |
| 18/11/2010 | 5,69 | 5,80 | 5,61 | 5,69 | -1,30% | 3,29% | 25.034 |
| 17/11/2010 | 5,91 | 5,99 | 5,69 | 5,76 | -2,53% | 5,06% | 476.786 |
| 16/11/2010 | 5,91 | 5,99 | 5,88 | 5,91 | -1,25% | 1,90% | 64.708 |
| 15/11/2010 | 5,95 | 5,99 | 5,95 | 5,99 | +0,63% | 0,63% | 81.860 |
| 12/11/2010 | 5,91 | 6,03 | 5,84 | 5,95 | +0,00% | 3,16% | 88.886 |